Journal Contents

Student Publications Homepage

ARTICLE CONTENTS

[Pages 325-354]
TOP OF ARTICLE

Introduction
I.  Background: The Economics of Prescription Drug Pricing
    A.  Overview of the Principles Behind Prescription Drug Differentials and Governmental Regulations
    B.  Impact of Price Regulations on the Innovation of Drugs
II.  Governmental Regulation Schemes Aimed at Reducing the Cost of Prescription Drugs to the Consumer
    A.  United States’ Health Care System
        1.  Private Health Care Systems and Cost Containment Strategies for Prescription Drugs Currently Employed
        2.  Public Health Care Systems and Cost Containment Strategies for Prescription Drugs Currently Employed in the United States
    B.  National Health Insurance System
        1.  Prescription Drug Coverage in France
        2.  Prescription Drug Coverage in Germany
    C.  National Health Service System
III.  Alternatives to Government Regulation of
Prescription Drug Cost

    A.  Pharmaceutical Industry Created Agreements
        1.  Prescription Drug Assistance Programs
        2.  RxHope.com
        3.  Pfizer for Living
        4.  PharmacyCareOneCard
    B.  State Government Prescription Drug Programs
        1.  Michigan’s Rebate and Reference Pricing Scheme
        2.  Wisconsin’s T-Rx Program
        3.  Maine Manufacturer Rebate Scheme
    C.  Federal Government Prescription Drug Programs
        1.  Medicare-Endorsed Prescription Drug Card Assistance Initiative
        2.  Medicare Prescription Drug Coverage Proposals
IV.  Discussion: Take-home Suggestions
    A.  Lessons Garnered from Overseas
        1.  The French Experience
        2.  A German Tutorial
        3.  The British Example
    B.  The Advantage of Private Industry-Driven Programs
    C.  Issues Regarding State-Sponsored Programs
    D.  The Potential for Federal Prescription Drug Programs
V.  Analysis: Recommendations for a Federal Medicare Prescription Drug Coverage Plan
Conclusion